These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36418912)

  • 1. Association of COVID-19 with diabetes: a systematic review and meta-analysis.
    Ssentongo P; Zhang Y; Witmer L; Chinchilli VM; Ba DM
    Sci Rep; 2022 Nov; 12(1):20191. PubMed ID: 36418912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.
    Rahmati M; Yon DK; Lee SW; Udeh R; McEVoy M; Kim MS; Gyasi RM; Oh H; López Sánchez GF; Jacob L; Li Y; Koyanagi A; Shin JI; Smith L
    J Med Virol; 2023 Jun; 95(6):e28833. PubMed ID: 37264687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Risk, and Clinical Course of New-Onset Diabetes in Long COVID: Protocol for a Systematic Review and Meta-Analysis of Cohort Studies.
    Talanki AS; Bajaj N; Trehan T; Thirunavukkarasu S
    JMIR Res Protoc; 2024 Jun; 13():e54853. PubMed ID: 38833277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis.
    Voleti N; Reddy SP; Ssentongo P
    Front Cardiovasc Med; 2022; 9():951314. PubMed ID: 36105535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis.
    Kastora S; Patel M; Carter B; Delibegovic M; Myint PK
    Endocrinol Diabetes Metab; 2022 May; 5(3):e00338. PubMed ID: 35441801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis.
    Bellia C; Andreadi A; D'Ippolito I; Scola L; Barraco S; Meloni M; Lauro D; Bellia A
    Front Endocrinol (Lausanne); 2023; 14():1215879. PubMed ID: 37732118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.
    Groff D; Sun A; Ssentongo AE; Ba DM; Parsons N; Poudel GR; Lekoubou A; Oh JS; Ericson JE; Ssentongo P; Chinchilli VM
    JAMA Netw Open; 2021 Oct; 4(10):e2128568. PubMed ID: 34643720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis.
    Zhang T; Mei Q; Zhang Z; Walline JH; Liu Y; Zhu H; Zhang S
    BMC Med; 2022 Nov; 20(1):444. PubMed ID: 36380329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis.
    Baldini T; Asioli GM; Romoli M; Carvalho Dias M; Schulte EC; Hauer L; Aguiar De Sousa D; Sellner J; Zini A
    Eur J Neurol; 2021 Oct; 28(10):3478-3490. PubMed ID: 33426733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis.
    Gabbai-Armelin PR; de Oliveira AB; Ferrisse TM; Sales LS; Barbosa ERO; Miranda ML; Salomão KB; Brighenti FL
    Eur J Clin Invest; 2021 Jun; 51(6):e13559. PubMed ID: 33772772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis.
    Li J; Li Y; Wang Z; Liu N; He L; Zhang H
    Front Public Health; 2023; 11():1170156. PubMed ID: 37304092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and burdens of incident diabetes in long COVID: a cohort study.
    Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2022 May; 10(5):311-321. PubMed ID: 35325624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis.
    Kaminska H; Szarpak L; Kosior D; Wieczorek W; Szarpak A; Al-Jeabory M; Gawel W; Gasecka A; Jaguszewski MJ; Jarosz-Chobot P
    Acta Diabetol; 2021 Aug; 58(8):1101-1110. PubMed ID: 33778910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Clinical Characteristics, and Clinical Outcomes of New-onset Diabetes Mellitus among COVID-19 Patients in Developing and Developed Countries: A Systematic Review.
    Junaid K; Dawood N; Daood M; Randhawa FA; Yousaf MK; Ahmad MS
    J Coll Physicians Surg Pak; 2023 Jun; 33(6):691-699. PubMed ID: 37300267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis.
    Ssentongo P; Ssentongo AE; Voleti N; Groff D; Sun A; Ba DM; Nunez J; Parent LJ; Chinchilli VM; Paules CI
    BMC Infect Dis; 2022 May; 22(1):439. PubMed ID: 35525973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
    PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the long-term physical and mental health consequences of SARS-CoV-2 infection: A systematic review and meta-analysis protocol.
    Kuodi P; Gorelik Y; Edelstein M
    PLoS One; 2022; 17(4):e0266232. PubMed ID: 35381027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.